Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy-Reference-Cited by-同舟云学术

Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy

Published:2023-04 Issue: Volume:141 Page:109159
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Georgieva Darina,Langley James,Hartkopf Katherine,Hawk Lisa,Margolis Amanda,Struck Aaron,Felton Elizabeth,Hsu David,Gidal Barry E.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference19 articles.

1. Developmental and epileptic encephalopathies: recognition and approaches to care;Raga;Epileptic Disord,2021

2. Epidiolex. Prescribing information. Greenwich Biosciences; 2021. Accessed January 15, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/210365s012s013lbl.pdf.

3. The proposed mechanisms of action of CBD in epilepsy;Gray;Epileptic Disord.,2020

4. Thiele EA, Marsh ED, French JA, GWPCARE4 Study Group. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018;391(10125):1085–96. doi: 10.1016/S0140-6736(18)30136-3.

5. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial;Patel;Epilepsia,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minor Cannabinoids as Inhibitors of Skin Inflammation: Chemical Synthesis and Biological Evaluation;Journal of Natural Products;2024-06-18

2. Medicinal plants for epileptic seizures: Phytoconstituents, pharmacology and mechanisms revisited;Journal of Ethnopharmacology;2024-02

3. Adherence and discontinuation of prescription cannabidiol for the management of seizure disorders at an integrated care center;Epilepsy Research;2024-02

4. Immunotoxicology of Drugs of Abuse;Reference Module in Biomedical Sciences;2024

5. Characterising people with focal drug-resistant epilepsy: A retrospective cohort study;Epilepsy & Behavior;2023-12